BiotechTube
Home/PEP-Therapy/Diego Germini, PhD
DG

Diego Germini, PhD

Head of Research

PEP-Therapy

Therapeutic Areas

Oncology

PEP-Therapy Pipeline

DrugIndicationPhase
PEP-010Recurrent and/or metastatic solid tumors (including pancreatic cancer)Phase 1a/b

Leadership Team at PEP-Therapy

AP
Antoine Prestat
Co-founder and CEO
JS
Jennifer Sengenès, PhD
Head of Strategy and Development
HA
Hatem Azim, MD, PhD
Chief Medical Officer
LD
Laura Dadon, PharmD
Head of Drug Development
View full PEP-Therapy profile